Condition: Metastatic Prostate Carcinoma
rs11017056
in
C10orf143
gene and
Metastatic Prostate Carcinoma
PMID 27143689
2016 Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
rs875858
in
VAC14
gene and
Metastatic Prostate Carcinoma
PMID 27143689
2016 Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.